1. Home
  2. SMTI vs RCEL Comparison

SMTI vs RCEL Comparison

Compare SMTI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$22.79

Market Cap

186.9M

Sector

Health Care

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.41

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
RCEL
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.9M
102.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SMTI
RCEL
Price
$22.79
$3.41
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$41.00
$8.67
AVG Volume (30 Days)
43.3K
191.4K
Earning Date
11-12-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$101,877,532.00
$72,401,000.00
Revenue This Year
$21.60
$13.12
Revenue Next Year
$16.70
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
30.52
20.59
52 Week Low
$18.90
$3.25
52 Week High
$38.68
$14.16

Technical Indicators

Market Signals
Indicator
SMTI
RCEL
Relative Strength Index (RSI) 43.72 41.31
Support Level $23.76 $3.30
Resistance Level $25.41 $3.71
Average True Range (ATR) 1.07 0.18
MACD -0.04 0.03
Stochastic Oscillator 3.33 34.78

Price Performance

Historical Comparison
SMTI
RCEL

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: